Method for treating hepatitis B carriers with minimal disease
US5308833A · kind A · utility
6Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 1992 |
| Grant date | May 3, 1994 |
| Priority date | — |
| Expiry date | Feb 6, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating minimal disease hepatitis B infection are disclosed. Minimal disease carriers are given thymosin .alpha.-1, or biologically active fragments or analogs thereof In this way, the indications of hepatitis B can be reduced or eliminated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.